[go: up one dir, main page]

EA202090809A1 - HIGH DOSE VALBENAZINE COMPOSITION AND COMPOSITION, RELATED METHODS AND KITS - Google Patents

HIGH DOSE VALBENAZINE COMPOSITION AND COMPOSITION, RELATED METHODS AND KITS

Info

Publication number
EA202090809A1
EA202090809A1 EA202090809A EA202090809A EA202090809A1 EA 202090809 A1 EA202090809 A1 EA 202090809A1 EA 202090809 A EA202090809 A EA 202090809A EA 202090809 A EA202090809 A EA 202090809A EA 202090809 A1 EA202090809 A1 EA 202090809A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
valbenazine
kits
high dose
related methods
Prior art date
Application number
EA202090809A
Other languages
Russian (ru)
Inventor
Ричард Александр Дж. Мур
Грегори А. Макклелланд
Кристофер Ф. О'Брайан
Original Assignee
Ньюрокрайн Байосайенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньюрокрайн Байосайенсиз, Инк. filed Critical Ньюрокрайн Байосайенсиз, Инк.
Priority claimed from PCT/US2018/051579 external-priority patent/WO2019060322A2/en
Publication of EA202090809A1 publication Critical patent/EA202090809A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предусмотрены твердые фармацевтические композиции с высоким содержанием лекарственного средства. Состав, пригодный для твердой фармацевтической композиции, включает в себя валбеназин или его фармацевтически приемлемую соль, силикатированную микрокристаллическую целлюлозу, изомальт, гидроксипропилметилцеллюлозу, частично предварительно клейстеризованный маисовый крахмал и стеарат магния.High drug content solid pharmaceutical compositions are provided. A formulation suitable for a solid pharmaceutical composition includes valbenazine or a pharmaceutically acceptable salt thereof, silicated microcrystalline cellulose, isomalt, hydroxypropyl methylcellulose, partially pregelatinized maize starch, and magnesium stearate.

EA202090809A 2017-09-28 2018-09-18 HIGH DOSE VALBENAZINE COMPOSITION AND COMPOSITION, RELATED METHODS AND KITS EA202090809A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762564951P 2017-09-28 2017-09-28
PCT/US2018/051579 WO2019060322A2 (en) 2017-09-21 2018-09-18 High dosage valbenazine formulation and compositions, methods, and kits related thereto

Publications (1)

Publication Number Publication Date
EA202090809A1 true EA202090809A1 (en) 2020-08-27

Family

ID=72235049

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090809A EA202090809A1 (en) 2017-09-28 2018-09-18 HIGH DOSE VALBENAZINE COMPOSITION AND COMPOSITION, RELATED METHODS AND KITS

Country Status (1)

Country Link
EA (1) EA202090809A1 (en)

Similar Documents

Publication Publication Date Title
MX2020002841A (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto.
CY1124669T1 (en) ANTI-ESTROGEN DRUGS TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLIOY
MX375639B (en) SUBSTITUTED HETEROCYCHYL DERIVATIVES AS CDK INHIBITORS
NZ721298A (en) Pharmaceutical compositions comprising azd9291
EA201692542A1 (en) INDANEOUS AND INDOLINE DERIVATIVES AND THEIR APPLICATION AS ACTIVATORS OF SOLUBLE GUANYLATSYCLASES
MX381735B (en) SOLID ORAL FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING SAME.
SA520411635B1 (en) Fused Ring Derivative as A2A Receptor Inhibitor
MX386777B (en) Pharmaceutical composition
WO2019194773A3 (en) The combination comprising linagliptin and metformin
MX383728B (en) PHARMACEUTICAL COMPOSITION.
JP2016108327A5 (en)
MX2020010618A (en) Pyrazolotriazolopyrimidine derivatives as a2a receptor antagonist.
EA202090913A1 (en) COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON
ATE451097T1 (en) VALSARTAN FORMULATIONS
WO2022106902A3 (en) Benzenesulfonamide derivatives and uses thereof
MX379576B (en) AZETIDINE DERIVATIVES
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
CY1121459T1 (en) COMPOSITION OF TIACUMICINE COMPOUNDS
EA202090809A1 (en) HIGH DOSE VALBENAZINE COMPOSITION AND COMPOSITION, RELATED METHODS AND KITS
MX2018002487A (en) Pharmaceutical compositions comprising 3-(5-amino-2-methyl-4-oxo- 4h-quinazolin-3-yl)-piperidine-2,6-dione.
IN2014MU00859A (en)
CY1124539T1 (en) PHARMACEUTICAL COMPOSITIONS OF THE 5-HT6 ANTAGONIST
MX2019005005A (en) Extended release tablet comprising a weight-loss drug.
EA202090315A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ALIMEMAZINE TARTRATE